View Latest Issue
Charlotte, NC—Although managing rheumatoid arthritis (RA) in patients who are pregnant or trying to conceive may be challenging, rheumatologists should aim to improve disease activity and pregnancy outcomes, according to Megan E. B. Clowse, MD, MPH, Associate Professor of Medicine, Director, Duke Autoimmunity in Pregnancy Registry, Duke University Medical Center, at the North Carolina Regional Association 2014 annual meeting.
Patients with rheumatoid arthritis who do not have a good handle on their disease may have poor sleep, research suggests.
Seville, Spain—A nurse-driven intervention appears to significantly improve osteoporosis care in older adults who present to the hospital after a fall, according to a preliminary study.
Psoriatic arthritis, a progressive, potentially debilitating type of arthritic inflammation, affects approximately 7 million people in the United States.
Tampa, FL—The grey wave that is washing over the United States will mean many more people will need help coping with their osteoarthritis pain, according to presenters at a symposium during the American Pain Society’s 2014 Annual Meeting.
Zitter Health Insights (ZHI) recently released the latest edition of its Co-Pay Offset Monitor, a publication that serves as a research tool to help identify trends in copay assistance. The group surveyed 100 rheumatologists, 100 patients who had used copay offset programs (COPs) for their medications over the previous 6 months, and 25 specialty pharmacists.
Tampa, FL—Current guidelines for the management of knee osteoarthritis (OA) from the American Academy of Orthopaedic Surgeons do not recommend intra-articular hyaluronic acid (IAHA) injection (ie, viscosupplementation) for patients with symptomatic OA because of the lack of data indicating that its use reduces pain.
Seville, Spain—Using a panel of 4 biomarkers is effective in selecting patients with rheumatoid arthritis who are most likely to meet the American College of Rheumatology (ACR) criteria for 50% improvement (ACR50) to 4 mg/kg/day of tocilizumab, according to a study presented at the recent 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (Siebuhr AS. Seville, Spain: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; 2014. Abstract OC24).
Currently, disease-modifying antirheumatic drugs (DMARDs) are classified as either biological or nonbiological. According to a recent study, however, this classification scheme is limiting and does not distinguish between the different types of DMARDs.
Quebec City, Quebec—The majority of Canadian rheumatologists who responded to a 19-item questionnaire about the use of medical marijuana for rheumatic conditions reported that they are not confident in this arena.
Page 1 of 3
Results 1 - 10 of 21
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology